Yumanity Therapeutics Inc Stock
Yumanity Therapeutics Inc Stock price
Key metrics
| Market capitalization | $4.48m |
| Enterprise Value | $3.32m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | negative |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-15.32m |
| Free Cash Flow (TTM) Free Cash Flow | $-8.33m |
| Cash position | $1.95m |
Is Yumanity Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Yumanity Therapeutics Inc Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Yumanity Therapeutics Inc:
Analyst Opinions
1 Analyst has issued a forecast Yumanity Therapeutics Inc:
Financial data from Yumanity Therapeutics Inc
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -15 -15 |
34%
34%
|
EBIT (Operating Income) EBIT | -15 -15 |
44%
44%
|
| Net Profit | -17 -17 |
46%
46%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Yumanity Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA.
| Head office | United States |
| CEO | Shawn Iadonato |
| Employees | 11 |
| Founded | 2008 |
| Website | www.kinetabio.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
